Carregant...
Gut Microbiota Changes in Patients With Major Depressive Disorder Treated With Vortioxetine
Vortioxetine hydrobromide is a common clinical medication for major depressive disorder (MDD). However, it remains unclear whether vortioxetine hydrobromide acts by affecting the structure and composition of gut microbiota. Here, we analyzed fecal samples from 28 healthy controls (HCs) and 26 patien...
Guardat en:
| Publicat a: | Front Psychiatry |
|---|---|
| Autors principals: | , , , , , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
Frontiers Media S.A.
2021
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8138160/ https://ncbi.nlm.nih.gov/pubmed/34025474 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fpsyt.2021.641491 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|